Clinical Trial Update: Lamivudine(LAM) Good Responder Study

View source ↗

Summary

Completed clinical trial update on lamivudine for chronic hepatitis B, focusing on good responders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: Hepatitis B, Chronic | Status: COMPLETED